Vyant Bio and Cyclica Announce a Strategic Collaboration to Identify Compounds to Treat CDKL5 Deficiency Disorder

NEXT STORY
AB Science announced the publication of a pathogenic mechanism triggered by mast cells in the amyotrophic lateral sclerosis (ALS) spinal cord that can be targeted by masitinib
PREV STORY
22nd Century Group Appoints Accomplished Life Sciences and Biotechnology Executive Anthony Johnson to Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Odiparcil development advances with recruitment of first patients in a new biomarker study in MPS VI children and adults

author_avatar
NASDAQ Market News

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

author_avatar
NASDAQ Market News

Athenex Names Timothy Cook as Senior Vice President of Global Commercial Oncology

Mr. Cook was Previously VP and Chief Operating Officer of Oncology at LillyBUFFALO, N.Y., ...

author_avatar
NASDAQ Market News